Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SDAT-IRC: DAPT vs SAPT Post-CABG
NCT03789916Phase 3Recruiting
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jan 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in coronary artery disease (CAD), sponsored by Università Campus Bio-Medico di Roma. Started Jan 2019; status: recruiting.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03789916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789916.